Evidence map›Paper›PMID 40443520›Full record

ArticleFrontiers in medicine2025

The ED

Yang Yang, Hao-Jing Xiong, He-Chen Xu, Hong-Qi Wu, Mi Chen, Ke Jiang, Xiao-Hua Zou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yang YangDepartment of Anesthesiology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Hao-Jing XiongDepartment of Anesthesiology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
He-Chen XuCollege of Anesthesiology, Guizhou Medical University, Guiyang, China.
Hong-Qi WuCollege of Anesthesiology, Guizhou Medical University, Guiyang, China.
Mi ChenDepartment of Anesthesiology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Ke JiangDepartment of Anesthesiology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Xiao-Hua ZouDepartment of Anesthesiology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Although remimazolam tosilate (RT) has demonstrated efficacy in elderly gastroscopy, its optimum dose for gastroscopy in elderly patients of varying ages is still unclear. The study aimed to determine the median effective dose (ED Methods: Sixty-one elderly patients were randomized into two groups: Group A (65-74 years, Results: The ED Conclusion: RT is a relatively safe sedative hypnotic that can provide a suitable sedative effect for elderly patients undergoing a gastroscopy. Clinical trial registration: http://www.chictr.org.cn, identifier ChiCTR2200062842.

Indexed as

effective doseelderlygastroscopygeriatricremimazolamup-and-down method

Identifiers

PMID40443520
PMCPMC12120960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.